80 research outputs found
Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention
<p>Abstract</p> <p>Background</p> <p>Restenosis represents the major limiting factor for the long-term efficacy of percutaneous coronary intervention (PCI). Several genetic factors involved in the regulation of the vascular system have been described to play a role in the pathogenesis of restenosis. We investigated whether the <it>EPHX2 K55R </it>polymorphism, previously linked to significantly higher risk for coronary heart disease (CHD), was associated with the occurrence of restenosis after PCI. The association with incident CHD should have been confirmed and a potential correlation of the <it>EPHX2 K55R </it>variant to an increased risk of hypertension was analysed.</p> <p>Methods</p> <p>An overall cohort of 706 patients was studied: This cohort comprised of 435 CHD patients who had undergone successful PCI. Follow-up coronary angiography in all patients was performed 6 months after intervention. Another 271 patients in whom CHD had been excluded by coronary angiography served as controls. From each patient EDTA-blood was drawn at the baseline ward round. Genomic DNA was extracted from these samples and genotyping was performed by real-time PCR and subsequent melting curve analysis.</p> <p>Results</p> <p>In CHD patients 6 month follow-up coronary angiography revealed a restenosis rate of 29.4%, classified as late lumen loss as well as lumen re-narrowing ≥ 50%.</p> <p>Statistical analysis showed an equal genotype distribution in restenosis patients and non-restenosis patients (A/A 82.0% and A/G + G/G 18.0% versus A/A 82.1% and A/G + G/G 17.9%). Moreover, neither a significant difference in the genotype distribution of CHD patients and controls nor an association with increased risk of hypertension was found.</p> <p>Conclusion</p> <p>The results of the present study indicate that the <it>EPHX2 K55R </it>polymorphism is not associated with restenosis after PCI, with incidence of CHD, or with an increased risk of hypertension and therefore, can not serve as a predictor for risk of CHD or restenosis after PCI.</p
Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy
BACKGROUND: To describe long-term changes in time of quality of life (QOL) and the relation with parotid salivary output in patients with head-and-neck cancer treated with radiotherapy. METHODS: Forty-four patients completed the EORTC-QLQ-C30(+3) and the EORTC-QLQ-H&N35 questionnaires before treatment, 6 weeks, 6 months, 12 months, and at least 3.5 years after treatment. At the same time points, stimulated bilateral parotid flow rates were measured. RESULTS: There was a deterioration of most QOL items after radiotherapy compared with baseline, with gradual improvement during 5 years follow-up. The specific xerostomia-related items showed improvement in time, but did not return to baseline. Global QOL did not alter significantly in time, although 41% of patients complained of moderate or severe xerostomia at 5 years follow-up. Five years after radiotherapy the mean cumulated parotid flow ratio returned to baseline but 20% of patients had a flow ratio <25%. The change in time of xerostomia was significantly related with the change in flow ratio (p = 0.01). CONCLUSION: Most of the xerostomia-related QOL scores improved in time after radiotherapy without altering the global QOL, which remained high. The recovery of the dry mouth feeling was significantly correlated with the recovery in parotid flow ratio
Survey of radio resource management issues and proposals for energy-efficient cellular networks that will cover billions of machines
The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients
The cause of Huntington disease (HD) is a polyglutamine repeat expansion of more than 36 units in the huntingtin protein, which is inversely correlated with the age at onset of the disease. However, additional genetic factors are believed to modify the course and the age at onset of HD. Recently, we identified the V471A polymorphism in the autophagy-related gene ATG7, a key component of the autophagy pathway that plays an important role in HD pathogenesis, to be associated with the age at onset in a large group of European Huntington disease patients. To confirm this association in a second independent patient cohort, we analysed the ATG7 V471A polymorphism in additional 1,464 European HD patients of the “REGISTRY” cohort from the European Huntington Disease Network (EHDN). In the entire REGISTRY cohort we could not confirm a modifying effect of the ATG7 V471A polymorphism. However, analysing a modifying effect of ATG7 in these REGISTRY patients and in patients of our previous HD cohort according to their ethnic origin, we identified a significant effect of the ATG7 V471A polymorphism on the HD age at onset only in the Italian population (327 patients). In these Italian patients, the polymorphism is associated with a 6-years earlier disease onset and thus seems to have an aggravating effect. We could specify the role of ATG7 as a genetic modifier for HD particularly in the Italian population. This result affirms the modifying influence of the autophagic pathway on the course of HD, but also suggests population-specific modifying mechanisms in HD pathogenesis
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
Background Huntington's disease is caused by a CAG repeat expansion in the huntingtin gene, HTT. Age at onset has been used as a quantitative phenotype in genetic analysis looking for Huntington's disease modifiers, but is hard to define and not always available. Therefore, we aimed to generate a novel measure of disease progression and to identify genetic markers associated with this progression measure. Methods We generated a progression score on the basis of principal component analysis of prospectively acquired longitudinal changes in motor, cognitive, and imaging measures in the 218 indivduals in the TRACK-HD cohort of Huntington's disease gene mutation carriers (data collected 2008–11). We generated a parallel progression score using data from 1773 previously genotyped participants from the European Huntington's Disease Network REGISTRY study of Huntington's disease mutation carriers (data collected 2003–13). We did a genome-wide association analyses in terms of progression for 216 TRACK-HD participants and 1773 REGISTRY participants, then a meta-analysis of these results was undertaken. Findings Longitudinal motor, cognitive, and imaging scores were correlated with each other in TRACK-HD participants, justifying use of a single, cross-domain measure of disease progression in both studies. The TRACK-HD and REGISTRY progression measures were correlated with each other (r=0·674), and with age at onset (TRACK-HD, r=0·315; REGISTRY, r=0·234). The meta-analysis of progression in TRACK-HD and REGISTRY gave a genome-wide significant signal (p=1·12 × 10−10) on chromosome 5 spanning three genes: MSH3, DHFR, and MTRNR2L2. The genes in this locus were associated with progression in TRACK-HD (MSH3 p=2·94 × 10−8 DHFR p=8·37 × 10−7 MTRNR2L2 p=2·15 × 10−9) and to a lesser extent in REGISTRY (MSH3 p=9·36 × 10−4 DHFR p=8·45 × 10−4 MTRNR2L2 p=1·20 × 10−3). The lead single nucleotide polymorphism (SNP) in TRACK-HD (rs557874766) was genome-wide significant in the meta-analysis (p=1·58 × 10−8), and encodes an aminoacid change (Pro67Ala) in MSH3. In TRACK-HD, each copy of the minor allele at this SNP was associated with a 0·4 units per year (95% CI 0·16–0·66) reduction in the rate of change of the Unified Huntington's Disease Rating Scale (UHDRS) Total Motor Score, and a reduction of 0·12 units per year (95% CI 0·06–0·18) in the rate of change of UHDRS Total Functional Capacity score. These associations remained significant after adjusting for age of onset. Interpretation The multidomain progression measure in TRACK-HD was associated with a functional variant that was genome-wide significant in our meta-analysis. The association in only 216 participants implies that the progression measure is a sensitive reflection of disease burden, that the effect size at this locus is large, or both. Knockout of Msh3 reduces somatic expansion in Huntington's disease mouse models, suggesting this mechanism as an area for future therapeutic investigation
Alteração superficial e pedogeomorfologia no sul do Complexo Bação - Quadrilátero Ferrífero (MG)
Alguns aspectos dos processos de alteração superficial e seus reflexos na pedogeomorfologia Quaternária na sub-bacia do alto Ribeirão Maracujá, no Complexo Bação, Quadrilátero Ferrífero, MG, são aqui caracterizados. São investigados caracteres relativos à dinâmica evolutiva de três vertentes (toposseqüências 1, 2 e 3), situadas sobre gnaisses, mas com graus de erodibilidade diferenciados. Nos segmentos de alta vertente das toposseqüências 1 e 2, os perfis de solos são pouco desenvolvidos e autóctones. Na toposseqüência 3, no mesmo segmento, ocorre um Latossolo com feições de aloctonia. Nos segmentos de meia vertente, das três toposseqüências ocorrem perfis latossólicos espessos, desenvolvidos a partir de sedimentos coluviais provindos da alta vertente. Nos segmentos de baixa vertente, há ruptura nos processos de transporte e deposição dos sedimentos, sendo o perfil de solo da toposseqüência 2 um Latossolo Câmbico autóctone e, nas toposseqüências 1 e 3, perfis desenvolvidos a partir de materiais alúvio-coluviais depositados sobre o saprolito gnáissico. Apesar de a dinâmica evolutiva das três vertentes corroborar os modelos geomorfológicos tropicais até o segmento de meia vertente, a jusante, a ruptura do coluvionamento na baixa vertente evidencia um recente desequilíbrio morfodinâmico. Além disso, as evidências micromorfológicas e mineralógicas não sinalizam correlação com susceptibilidade erosiva diferenciada verificada na área
Risk Factors of Anaemia Among Rural School Children in Kenitra, Morocco
Objective: To determine the prevalence of anaemia and factors
associated with iron deficiency among school children in rural Kenitra,
Morocco. Methods: 295 students between 6 and 16 years old composed
the study group. The level of haemoglobin was measured in a group of
295 school children. The iron status was determined by ferritin level
in serum, and anaemia was defined when haemoglobin <11.5 g/dl. Iron
deficiency was defined as ferritin level <5 μg/l. A
questionnaire was developed to obtain information on the socio-economic
and demographic status of the family such as the size of household, the
income and possessions as well as educational status of the parents.
Results: The mean haemoglobin concentration was 12.4 g/dl in boys and
12.5 g/dl in girls, whereas the mean ferritin level was 26.7 Wg/l in
boys and 27.9 Wg/l in girls. The overall prevalence of anaemia in the
studied population was 12.2 % and iron deficiency was 20.4 %. There was
a significant relationship between education of the mother and anaemia
in children (p= 0.01). Serum ferritin (SF), serum iron concentrations
and mean corpuscular volume (MCV) were significantly correlated with
haemoglobin by multiple regression analysis. However, using logistic
regression analysis, the results showed that anaemia was not
significantly associated with gender, parents' employment and monthly
family income. Conclusion: Anaemia remains a common problem in the
young children particularly the primary education school boys of the
households of low income. The results suggest also, that iron
deficiency is an important determinant of anaemia in this population;
however, whole anaemia cannot be solely explained by iron deficiency.
Further studies are needed to consider micronutrients status and
exposure to environmental pollutant
Recommended from our members
Optimal NIV Medicare Access Promotion: Patients With Thoracic Restrictive Disorders
The existing coverage criteria for noninvasive ventilation (NIV) do not recognize the benefits of early initiation of NIV for those with thoracic restrictive disorders and do not address the unique needs for daytime support as the patients progress to ventilator dependence. This document summarizes the work of the thoracic restrictive disorder Technical Expert Panel working group. The most pressing current coverage barriers identified were: (1) delays in implementing NIV treatment; (2) lack of coverage for many nonprogressive neuromuscular diseases; and (3) lack of clear policy indications for home mechanical ventilation (HMV) support in thoracic restrictive disorders. To best address these issues, we make the following key recommendations: (1) given the need to encourage early initiation of NIV with bilevel positive airway pressure devices, we recommend that symptoms be considered as a reason to initiate therapy even at mildly reduced FVCs; (2) broaden CO2 measurements to include surrogates such as transcutaneous, end-tidal, or venous blood gas; (3) expand the diagnostic category to include phrenic nerve injuries and disorders of central drive; (4) allow a bilevel positive airway pressure device to be advanced to an HMV when the vital capacity is 18 h per day. Adoption of these proposed recommendations would result in the right device, at the right time, for the right type of patients with thoracic restrictive disorders
- …